Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
letter
. 2014 Nov;58(11):7017–7018. doi: 10.1128/AAC.02934-14

A blaVIM-2 Plasmid Disseminating in Extensively Drug-Resistant Clinical Pseudomonas aeruginosa and Serratia marcescens Isolates

Elisabet Vilacoba a, Cecilia Quiroga a, Mariano Pistorio b, Angela Famiglietti c, Hernán Rodríguez c, Jaime Kovensky d, Maxime Déraspe e,f, Frédéric Raymond f,g, Paul H Roy e,f, Daniela Centrón a,
PMCID: PMC4249447  PMID: 25182641

LETTER

Infections caused by carbapenem-resistant Enterobacteriaceae isolates are an issue of major global concern (1). Genes coding for metallo-β-lactamases (MβLs) identified in clinical isolates are associated with mobile elements and subject to horizontal genetic transfer (HGT) events (26). VIM-2 is present on numerous plasmids, but only pNOR-2000 from Pseudomonas aeruginosa COL-1 from France (7, 8) and pLD209 from Pseudomonas putida LD209 from Argentina (9) have been completely sequenced. Here, we report the complete sequence and characterization of plasmid pDCPR1 harboring a blaVIM-2 gene cassette in a Tn402-type class 1 integron, which was isolated from two extensively drug-resistant strains: P. aeruginosa 802 (from a burn patient at the Hospital Municipal de Quemados, Argentina, 2005) and S. marcescens 68313 (Sanatorio Sagrado Corazón, Argentina, 2012).

Isolates were identified at the species level using a Vitek 2 Compact instrument (bioMérieux). Antimicrobial susceptibility was determined by the disk diffusion method performed in agar as recommended by the CLSI (10). DNA was isolated from P. aeruginosa 802 and Serratia marcescens 68313 using a Master Pure DNA purification kit (Epicentre, Madison, WI). A library was prepared from 500 ng of total DNA. Sequencing was performed using an Illumina MiSeq sequencer and assembled using Ray (11). A single contig from the S. marcescens strain and three contigs from the P. aeruginosa strain all corresponded to the same plasmid sequence, which was confirmed in the latter by three PCRs and sequencing (data not shown). The complete sequence of plasmid pDCPR1 was thus determined.

pDCPR1 was 18,182 bp long. We observed that pDCPR1 is identical (except for 2 nucleotides [nt]) to part of pLD209 (KF840720) (9), including the replicase gene (repA), the partitioning system genes (trfB, parA, and parB), the Tn402-like class 1 integron harboring a blaVIM-2 gene cassette, and genes encoding several hypothetical proteins. Because only genes involved in conjugal transfer and virulence from pLD209 (20,221 bp) are deleted in pDCPR1 (Fig. 1), we discarded the possibility of a cointegration process in the formation of pLD209. The two plasmids appear to be a novel replicon type. Although not conjugative, pDCPR1 retains the putative oriT of pLD209 (TATCCTG′C; the prime represents the nickase cut site in oriT) and should be mobilizable.

FIG 1.

FIG 1

Structure of plasmids pLD209 and pDCPR1. The gray solid bars represent identical regions; position 1 in the figure corresponds to position 1 in the GenBank entry for pLD209 (KF840720.1) (9) and position 7263 in the GenBank entry for pDCPR1 (KJ577613). Most of the remaining region of pLD209 (virulence [vir] genes) has been omitted for better resolution. The 25-nt IRi and IRt represent the ends of the Tn402-like transposon; DRi and DRt (5′-GTTTT-3′) are the initial and terminal direct repeats; the 38-nt external IRs, IRie and IRte, and the external direct repeats, DRie and DRte (5′-TATTC-3′), are as defined for pLD209 (KF840720.1); open reading frame (Orf) names from pDCPR1 are used for pLD209 to reflect identities.

P. putida LD209 was isolated in Argentina in 2009, and P. aeruginosa 802 was isolated in Argentina in 2005. Therefore, the presumptive deletion of pLD209 which gave rise to pDCPR1 occurred before 2005. Since then, it is likely that both plasmids, pLD209 and pDCPR1, are circulating in Argentinean samples. Plasmid pDCPR1 was found in two different genera (Pseudomonas and Serratia) 7 years apart, and no single-nucleotide polymorphisms (SNPs) or indels were found. The plasmid was capable of surviving in nosocomial environments while maintaining its structure. These features suggest that bacteria have found an efficient genetic platform for spreading carbapenem resistance among clinical species.

This work not only characterizes a plasmid circulating in P. aeruginosa and S. marcescens, it also is the first report of a blaVIM-2 gene cassette in S. marcescens in Argentina. The acquisition of plasmid pDCPR1 by S. marcescens reinforces the global concern about the dissemination of broad-host-range plasmids involved in the evolution of pan-drug resistance in almost all human-pathogenic species in strongly selective environments.

Nucleotide sequence accession number.

The complete sequence of plasmid pDCPR1 has been submitted to GenBank under accession number KJ577613.

ACKNOWLEDGMENTS

D.C., C.Q., and M.P. are career investigators of CONICET. E.V. is recipient of a doctoral fellowship from CONICET. This study was supported by a grant from BID/OC ANPCyT (0034), Buenos Aires, Argentina, and by a grant from UBACYT (20020100100417) Programación 2011-2014, Buenos Aires, Argentina, to D.C.

Footnotes

Published ahead of print 2 September 2014

REFERENCES

  • 1.Savard P, Carroll KC, Wilson LE, Perl TM. 2013. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos. Infect. Control Hosp. Epidemiol. 34:730–739. 10.1086/671003. [DOI] [PubMed] [Google Scholar]
  • 2.Castanheira M, Toleman MA, Jones RN, Schmidt FJ, Walsh TR. 2004. Molecular characterization of a β-lactamase gene, blaGIM-1, encoding a new subclass of metallo-β-lactamase. Antimicrob. Agents Chemother. 48:4654–4661. 10.1128/AAC.48.12.4654-4661.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Nastro M, Monge R, Zintgraff J, Vaulet LG, Boutureira M, Famiglietti A, Rodriguez CH. 2013. First nosocomial outbreak of VIM-16-producing Serratia marcescens in Argentina. Clin. Microbiol. Infect. 19:617–619. 10.1111/j.1469-0691.2012.03978.x. [DOI] [PubMed] [Google Scholar]
  • 4.Peleg AY, Franklin C, Bell JM, Spelman DW. 2005. Dissemination of the metallo-β-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia. Clin. Infect. Dis. 41:1549–1556. 10.1086/497831. [DOI] [PubMed] [Google Scholar]
  • 5.Pfeifer Y, Wilharm G, Zander E, Wichelhaus TA, Gottig S, Hunfeld KP, Seifert H, Witte W, Higgins PG. 2011. Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J. Antimicrob. Chemother. 66:1998–2001. 10.1093/jac/dkr256. [DOI] [PubMed] [Google Scholar]
  • 6.Wachino J, Yoshida H, Yamane K, Suzuki S, Matsui M, Yamagishi T, Tsutsui A, Konda T, Shibayama K, Arakawa Y. 2011. SMB-1, a novel subclass B3 metallo-β-lactamase, associated with ISCR1 and a class 1 integron, from a carbapenem-resistant Serratia marcescens clinical isolate. Antimicrob. Agents Chemother. 55:5143–5149. 10.1128/AAC.05045-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Bonnin RA, Poirel L, Nordmann P, Eikmeyer FG, Wibberg D, Puhler A, Schluter A. 2013. Complete sequence of broad-host-range plasmid pNOR-2000 harbouring the metallo-β-lactamase gene blaVIM-2 from Pseudomonas aeruginosa. J. Antimicrob. Chemother. 68:1060–1065. 10.1093/jac/dks526. [DOI] [PubMed] [Google Scholar]
  • 8.Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, Nordmann P. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891–897. 10.1128/AAC.44.4.891-897.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Marchiaro PM, Brambilla L, Moran-Barrio J, Revale S, Pasteran F, Vila AJ, Viale AM, Limansky AS. 2014. The complete nucleotide sequence of the carbapenem resistance-conferring conjugative plasmid pLD209 from a Pseudomonas putida clinical strain reveals a chimeric design formed by modules derived from both environmental and clinical bacteria. Antimicrob. Agents Chemother. 58:1816–1821. 10.1128/AAC.02494-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.CLSI. 2014. Performance standards for antimicrobial susceptibility testing; 23rd informational supplement. CLSI document M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA. [Google Scholar]
  • 11.Boisvert S, Laviolette F, Corbeil J. 2010. Ray: simultaneous assembly of reads from a mix of high-throughput sequencing technologies. J. Comput. Biol. 17:1519–1533. 10.1089/cmb.2009.0238. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES